116 related articles for article (PubMed ID: 3197822)
1. Prognostic factors in Hodgkin's disease stage IV.
Specht L; Nissen NI
Eur J Haematol; 1988 Oct; 41(4):359-67. PubMed ID: 3197822
[TBL] [Abstract][Full Text] [Related]
2. Hodgkin's disease and age.
Specht L; Nissen NI
Eur J Haematol; 1989 Aug; 43(2):127-35. PubMed ID: 2792320
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in Hodgkin's disease stage III with special reference to tumour burden.
Specht L; Nissen NI
Eur J Haematol; 1988 Jul; 41(1):80-7. PubMed ID: 3402591
[TBL] [Abstract][Full Text] [Related]
4. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
5. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
[TBL] [Abstract][Full Text] [Related]
6. Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment.
Specht L; Nordentoft AM; Cold S; Clausen NT; Nissen NI
Cancer; 1988 Apr; 61(8):1719-27. PubMed ID: 3349432
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.
Vlachaki MT; Hagemeister FB; Fuller LM; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):593-9. PubMed ID: 9231684
[TBL] [Abstract][Full Text] [Related]
8. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic implications of mediastinal involvement in advanced Hodgkin's disease.
Specht L; Nissen NI; Walbom-Jørgensen S
Scand J Haematol; 1985 Aug; 35(2):166-73. PubMed ID: 3840275
[TBL] [Abstract][Full Text] [Related]
10. The EORTC treatment of early stages of Hodgkin's disease: the role of radiotherapy.
Tubiana M; Henry-Amar M; Hayat M; Burgers M; Qasim M; Somers R; Sizoo W; van der Schueren E
Int J Radiat Oncol Biol Phys; 1984 Feb; 10(2):197-210. PubMed ID: 6368491
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of tumour burden in Hodgkin's disease PS I and II.
Specht L; Nissen NI
Scand J Haematol; 1986 Apr; 36(4):367-75. PubMed ID: 3754976
[TBL] [Abstract][Full Text] [Related]
12. Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy.
Brusamolino E; Orlandi E; Morra E; Castelli G; Pagnucco G; Livraghi A; Astori C; Santagostino A; Lazzarino M; Bernasconi C
Ann Oncol; 1994; 5 Suppl 2():53-7. PubMed ID: 7515648
[TBL] [Abstract][Full Text] [Related]
13. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
[TBL] [Abstract][Full Text] [Related]
14. Tumour burden in early stage Hodgkin's disease: the single most important prognostic factor for outcome after radiotherapy.
Specht L; Nordentoft AM; Cold S; Clausen NT; Nissen NI
Br J Cancer; 1987 May; 55(5):535-9. PubMed ID: 3300762
[TBL] [Abstract][Full Text] [Related]
15. A multivariate analysis of prognostic factors in adult Hodgkin's disease.
Dienstbier Z; Chytrý P; Hermanská Z; Melínová L; Pĕnicka P; Maríková E
Neoplasma; 1989; 36(4):447-56. PubMed ID: 2770931
[TBL] [Abstract][Full Text] [Related]
16. Hodgkin's disease stages I and II with infradiaphragmatic presentation: a rare and prognostically unfavourable combination.
Specht L; Nissen NI
Eur J Haematol; 1988 May; 40(5):396-402. PubMed ID: 3378595
[TBL] [Abstract][Full Text] [Related]
17. High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
Wheeler C; Eickhoff C; Elias A; Ibrahim J; Ayash L; McCauley M; Mauch P; Schwartz G; Eder JP; Mazanet R; Ferrara J; Rimm IJ; Guinan E; Bierer B; Gilliland G; Churchill WH; Ault K; Parsons S; Antman K; Schnipper L; Tepler I; Gaynes L; Frei E; Kadin M; Antin J
Biol Blood Marrow Transplant; 1997 Jun; 3(2):98-106. PubMed ID: 9267670
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
[TBL] [Abstract][Full Text] [Related]
19. MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.
Hutchinson RJ; Fryer CJ; Davis PC; Nachman J; Krailo MD; O'Brien RT; Collins RD; Whalen T; Reardon D; Trigg ME; Gilchrist GS
J Clin Oncol; 1998 Mar; 16(3):897-906. PubMed ID: 9508171
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease.
Jagannath S; Armitage JO; Dicke KA; Tucker SL; Velasquez WS; Smith K; Vaughan WP; Kessinger A; Horwitz LJ; Hagemeister FB
J Clin Oncol; 1989 Feb; 7(2):179-85. PubMed ID: 2644397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
